Rotavirus injury compensation
Public hearing is planned to discuss HHS' proposal to add "vaccines containing live, oral rhesus-based rotavirus" to the National Vaccine Injury Compensation Program's vaccine injury table as a distinct category, with intussusception listed as a covered injury. The hearing will occur in conjunction with the Advisory Commission on Childhood Vaccines' next meeting, scheduled for early December in FDA's Parklawn Building in Rockville, Md. The notice of proposed rulemaking, published in the Federal Register July 13, would cover intussusception cases that "have an onset interval of 30 days"
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth